HEATHER BYLANDER: Open Payments
NPI 1174384531 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 41 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,811 · 2025 $1,164
Food & beverage: $1,164
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $207 |
| AstraZeneca Pharmaceuticals LP | 7 | $202 |
| Lilly USA, LLC | 4 | $144 |
| PFIZER INC. | 5 | $118 |
| Gilead Sciences, Inc. | 1 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| ABBVIE INC. | 3 | $52 |
| Exact Sciences Corporation | 2 | $50 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Amgen Inc. | 2 | $38 |
Products named: AIRSUPRA, Ozempic, MOUNJARO, Yeztugo, ELIQUIS, Kerendia, Wegovy, The Cologuard Plus Collection Kit.
Industry payments across TX — which companies pay providers there.
